Iddo Z Ben-Dov1, Jeremy D Kark. 1. Laboratory of RNA Molecular Biology, The Rockefeller University, New York, NY 10065, USA. iben@rockefeller.edu
Abstract
BACKGROUND: Kidney disease is commonly accompanied by hyperuricemia. However, the contribution of serum uric acid (SUA) to kidney injury is debated. Our objective was to assess the long-term prediction of renal failure by SUA. METHODS: Visit 2 participants in the Jerusalem Lipid Research Clinic cohort with normal baseline kidney function were followed for 24-28 years. SUA levels were assessed for associations with acute renal failure (ARF) and chronic renal failure (CRF) as defined by hospital discharge records, and mortality, ascertained through linkage with the national population registry. RESULTS: Among 2449 eligible participants (1470 men, 979 women aged 35-78 years in 1976-79), SUA was positively linked with male sex, serum creatinine and components of the metabolic syndrome but was lower in smokers and in diabetic subjects. The 22- to 25-year incidence of hospital-diagnosed kidney failure (145 first events, 67% CRF) and the 24- to 28-year mortality (587 events) were higher in subject with hyperuricemia (>6.5 mg/dL in men and >5.3 mg/dL in women, reflecting the upper quintiles), independent of baseline kidney function and covariates. Hyperuricemia conferred adjusted hazard ratios of 1.36 (P = 0.003), 2.14 (P < 0.001) and 2.87 (P = 0.003) for mortality, CRF and ARF, respectively. CONCLUSIONS: SUA predicts renal failure incidence and all-cause mortality independently of demographic and clinical covariates. These results lend support to the undertaking of clinical trials to examine the effect of uric acid-lowering strategies on kidney outcomes.
BACKGROUND:Kidney disease is commonly accompanied by hyperuricemia. However, the contribution of serum uric acid (SUA) to kidney injury is debated. Our objective was to assess the long-term prediction of renal failure by SUA. METHODS: Visit 2 participants in the Jerusalem Lipid Research Clinic cohort with normal baseline kidney function were followed for 24-28 years. SUA levels were assessed for associations with acute renal failure (ARF) and chronic renal failure (CRF) as defined by hospital discharge records, and mortality, ascertained through linkage with the national population registry. RESULTS: Among 2449 eligible participants (1470 men, 979 women aged 35-78 years in 1976-79), SUA was positively linked with male sex, serum creatinine and components of the metabolic syndrome but was lower in smokers and in diabetic subjects. The 22- to 25-year incidence of hospital-diagnosed kidney failure (145 first events, 67% CRF) and the 24- to 28-year mortality (587 events) were higher in subject with hyperuricemia (>6.5 mg/dL in men and >5.3 mg/dL in women, reflecting the upper quintiles), independent of baseline kidney function and covariates. Hyperuricemia conferred adjusted hazard ratios of 1.36 (P = 0.003), 2.14 (P < 0.001) and 2.87 (P = 0.003) for mortality, CRF and ARF, respectively. CONCLUSIONS:SUA predicts renal failure incidence and all-cause mortality independently of demographic and clinical covariates. These results lend support to the undertaking of clinical trials to examine the effect of uric acid-lowering strategies on kidney outcomes.
Authors: Michel Chonchol; Michael G Shlipak; Ronit Katz; Mark J Sarnak; Anne B Newman; David S Siscovick; Bryan Kestenbaum; Jan Kirk Carney; Linda F Fried Journal: Am J Kidney Dis Date: 2007-08 Impact factor: 8.860
Authors: Mehmet Kanbay; Adem Ozkara; Yusuf Selcoki; Bunyamin Isik; Faruk Turgut; Nuket Bavbek; Ebru Uz; Ali Akcay; Ramazan Yigitoglu; Adrian Covic Journal: Int Urol Nephrol Date: 2007-08-15 Impact factor: 2.370
Authors: Dalila B Corry; Pirooz Eslami; Kei Yamamoto; Michael D Nyby; Hirofumi Makino; Michael L Tuck Journal: J Hypertens Date: 2008-02 Impact factor: 4.844
Authors: A Ahsan Ejaz; Wei Mu; Duk-Hee Kang; Carlos Roncal; Yuri Y Sautin; George Henderson; Isabelle Tabah-Fisch; Birgit Keller; Thomas M Beaver; Takahiko Nakagawa; Richard J Johnson Journal: Clin J Am Soc Nephrol Date: 2006-12-06 Impact factor: 8.237
Authors: Hakan Nacak; Merel van Diepen; Abdul R Qureshi; Juan J Carrero; Theo Stijnen; Friedo W Dekker; Marie Evans Journal: Nephrol Dial Transplant Date: 2015-07-16 Impact factor: 5.992
Authors: Bertram L Kasiske; Teresa Anderson-Haag; Ajay K Israni; Roberto S Kalil; Paul L Kimmel; Edward S Kraus; Rajiv Kumar; Andrew A Posselt; Todd E Pesavento; Hamid Rabb; Michael W Steffes; Jon J Snyder; Matthew R Weir Journal: Am J Kidney Dis Date: 2015-03-17 Impact factor: 8.860
Authors: Keiko I Greenberg; Mara A McAdams-DeMarco; Anna Köttgen; Lawrence J Appel; Josef Coresh; Morgan E Grams Journal: Clin J Am Soc Nephrol Date: 2015-02-25 Impact factor: 8.237
Authors: Bertram L Kasiske; Teresa Anderson-Haag; Hassan N Ibrahim; Todd E Pesavento; Matthew R Weir; Joseph M Nogueira; Fernando G Cosio; Edward S Kraus; Hamid H Rabb; Roberto S Kalil; Andrew A Posselt; Paul L Kimmel; Michael W Steffes Journal: Am J Kidney Dis Date: 2013-03-22 Impact factor: 8.860